Matches in Wikidata for { <http://www.wikidata.org/entity/Q90981923> ?p ?o ?g. }
Showing items 1 to 47 of
47
with 100 items per page.
- Q90981923 description "article scientifique publié en 2018" @default.
- Q90981923 description "artículu científicu espublizáu n'agostu de 2018" @default.
- Q90981923 description "im August 2018 veröffentlichter wissenschaftlicher Artikel" @default.
- Q90981923 description "scientific article published on 07 August 2018" @default.
- Q90981923 description "wetenschappelijk artikel" @default.
- Q90981923 description "наукова стаття, опублікована в серпні 2018" @default.
- Q90981923 name "Unexpected high multiple sclerosis activity after switching from fingolimod to alemtuzumab" @default.
- Q90981923 name "Unexpected high multiple sclerosis activity after switching from fingolimod to alemtuzumab" @default.
- Q90981923 type Item @default.
- Q90981923 label "Unexpected high multiple sclerosis activity after switching from fingolimod to alemtuzumab" @default.
- Q90981923 label "Unexpected high multiple sclerosis activity after switching from fingolimod to alemtuzumab" @default.
- Q90981923 prefLabel "Unexpected high multiple sclerosis activity after switching from fingolimod to alemtuzumab" @default.
- Q90981923 prefLabel "Unexpected high multiple sclerosis activity after switching from fingolimod to alemtuzumab" @default.
- Q90981923 P1433 Q90981923-42FDD2AE-4061-4385-98E6-83CE9BD1F67B @default.
- Q90981923 P1476 Q90981923-08B02B6A-77F0-470C-80DB-8D81B0569ACD @default.
- Q90981923 P2093 Q90981923-566EC29F-2103-411F-9344-181F97B39722 @default.
- Q90981923 P2093 Q90981923-A733D60A-58AE-4634-811E-9CC227264145 @default.
- Q90981923 P2093 Q90981923-B871C6D0-F697-4CCD-842C-9374067DDD2A @default.
- Q90981923 P2093 Q90981923-E0F71970-565F-4CE5-9BE1-E692E184D0AE @default.
- Q90981923 P2093 Q90981923-E44C98B9-AA7B-4825-A878-5F55E278F36D @default.
- Q90981923 P2093 Q90981923-F73451F7-2C17-48A5-BA78-FD2E1703B4BE @default.
- Q90981923 P304 Q90981923-A0642252-7DFB-464B-9319-121655086E4B @default.
- Q90981923 P31 Q90981923-2CC2127B-31A9-4E8F-9C76-2AB6E35A2074 @default.
- Q90981923 P356 Q90981923-BDBC93D5-F2E9-4F68-8664-F06B0E95B538 @default.
- Q90981923 P478 Q90981923-C03DE40F-9AEB-4819-B135-90E1B754925F @default.
- Q90981923 P50 Q90981923-62FDFCFE-1987-492E-864E-0E7A1DBA0206 @default.
- Q90981923 P50 Q90981923-BE859C89-5830-4CCD-838D-B300413F838A @default.
- Q90981923 P577 Q90981923-A24C6692-6B46-4730-86AC-C65B3AD8266C @default.
- Q90981923 P698 Q90981923-597E335A-4312-4007-9F40-C0C5481030BA @default.
- Q90981923 P356 J.MSARD.2018.08.006 @default.
- Q90981923 P698 30114625 @default.
- Q90981923 P1433 Q26842267 @default.
- Q90981923 P1476 "Unexpected high multiple sclerosis activity after switching from fingolimod to alemtuzumab" @default.
- Q90981923 P2093 "Béatrice Pignolet" @default.
- Q90981923 P2093 "Damien Biotti" @default.
- Q90981923 P2093 "David Brassat" @default.
- Q90981923 P2093 "Fabrice Bonneville" @default.
- Q90981923 P2093 "Hervé Dumas" @default.
- Q90981923 P2093 "Jean François Lafontan" @default.
- Q90981923 P304 "216-218" @default.
- Q90981923 P31 Q13442814 @default.
- Q90981923 P356 "10.1016/J.MSARD.2018.08.006" @default.
- Q90981923 P478 "25" @default.
- Q90981923 P50 Q56529059 @default.
- Q90981923 P50 Q57343387 @default.
- Q90981923 P577 "2018-08-07T00:00:00Z" @default.
- Q90981923 P698 "30114625" @default.